Skip to main content

Novartis news and events in 2026

Novartis news, hiring, layoffs, acquisitions and Reddit, Glassdoor, podcast and web signals in one place. Every row is dated and links to its source.

PublicPharmaceutical Manufacturing10,000+ employeesnovartis.comLinkedIn

Get Novartis' live signals in Claude or ChatGPT, or by API

AskWhat changed at Novartis this week? Use Autobound signals for novartis.com.
Dated updates
77
Last event
Oct 28, 2026
Open rolesSnapshot Nov 3, 2026
355

Source: Autobound Signal API · 77 signals tracked for Novartis · updated

Overview

Novartis by topic

Latest events

Latest Novartis events

  1. In development
    Monte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)Novartis initiated a second Phase 2 clinical study evaluating the VAV1-directed molecular glue degrader MRT-6160 (DDY391) in patients with active moderate to severe psoriatic arthritis.
  2. Revenue
  3. In development
    Kisqali® shows clinically meaningful overall survival in broadest HR+/HER2- early breast cancer population at high risk of recurrenceNovartis announced positive six-year follow-up results from the Phase III NATALEE trial evaluating Kisqali plus endocrine therapy for stage II and III HR+/HER2- early breast cancer.
  4. Partnership
  5. Revenue
    3 steps for taking on Novartis in radiopharma: Curium up firstNovartis generated $1.7 billion in revenue from its radioligand therapies Lutathera and Pluvicto in the first half of the year.
  6. In development
    Novartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR)Novartis's drug Cosentyx® (secukinumab) received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP), recommending it for marketing authorization to treat polymyalgia rheumatica (PMR).
  7. News
  8. Investment
    Novartis strengthens Tyrol as a business location with new investments in KufsteinNovartis has invested approximately 1.8 billion Euro in Austria over the past ten years, strengthening its sites in Kundl and Schaftenau.
  9. Asset sale
    Novartis India Receives Detailed Public Statement for ₹552.49 Crore Open OfferNovartis AG has agreed to sell its 70.68% stake in Novartis India Limited to a consortium led by WaveRise Investments Limited for a total consideration of ₹1,445.89 crore.
  10. In development
    Novartis provides update on delpacibart etedesiran (del-desiran) Phase III HARBOR study for the treatment of myotonic dystrophy type 1 (DM1)Novartis is planning to meet with the FDA to discuss next steps for its delpacibart braxlosiran (del-brax) therapy for facioscapulohumeral muscular dystrophy (FSHD).

Showing 10 of 25 events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Novartis with the Signal API

One POST /v1/companies/enrich call with novartis.com returns every signal type for Novartis, each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"novartis.com","limit":20}'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Novartis questions

What is the latest news on Novartis?
On Oct 28, 2026, globenewswire.com reported: Monte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391). This page tracks 25 news events for Novartis since Jul 7, 2026, each with a date and a source link.
What is going on with Novartis?
In the 90 days to Nov 4, 2026, Autobound tracked 17 news events, 3 hiring snapshots, 1 reported layoff round, 41 signals for Novartis. The newest story is from Oct 28, 2026 (In development), reported by globenewswire.com.
Is Novartis laying off employees?
bazonline.ch reported on Sep 2, 2026: Novartis cuts 130 jobs in Basel: Biologics production in Kleinbasel to be abandoned. Autobound lists 2 reported layoff rounds for Novartis. Each row states what its source reported, not a confirmed total.
Has Novartis announced any acquisitions?
The latest deal story is from Jul 7, 2026. novartis.com reported: Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients. The acquisitions page lists 1 deal with a source for each.
What else does Autobound track for Novartis?
Beyond news and filings, Autobound lists 52+ signals for Novartis from 7 sources: Glassdoor (15+), Website changes (15+), Patents (11), Reddit (4), Web traffic (4), Employee growth (2), LinkedIn (1). See the Novartis signals page for the dated list.
Is Novartis hiring right now?
Yes. As of Nov 3, 2026, Novartis had 355 open roles, and Sales had the most with 15.

Page updated , the date of the newest row on this page.

Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.

Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.

Data as of .

How this data is built →Get it from the Signal API →